OPKO Health, Inc. (OPK) Deep Dive Video
Summary
OPKO’s diagnostics reset and Pfizer-backed NGENLA royalties create asymmetric upside, but cash burn, debt and partner dependence make OPK highly speculative.
View OPK stock page · Read the OPK research report
Loading the video player…